Skip to main content
Tata Chemicals Ltd logo

Tata Chemicals Ltd — Investor Relations & Filings

Ticker · TATACHEM ISIN · INE092A01019 LEI · 335800H6MURUA6FBOW17 BSE.NS Manufacturing
Open in API
Filings indexed 2,734 across all filing types
Latest filing 2026-02-02 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS TATACHEM

About Tata Chemicals Ltd

https://www.tatachemicals.com/

Tata Chemicals Ltd provides chemistry-led solutions through its Basic Chemistry and Specialty Products segments. It is a leading global producer of soda ash and sodium bicarbonate, serving sectors such as glass, detergents, pharmaceuticals, and food processing. The specialty portfolio includes agro sciences, nutritional sciences, and material sciences, with a focus on prebiotics, highly dispersible silica, and crop protection through its subsidiary, Rallis India. The company operates manufacturing facilities across four continents and invests in energy sciences, specifically lithium-ion battery materials. Its operations are characterized by innovation-driven R&D and sustainable manufacturing practices. By integrating science with sustainability, the company delivers essential ingredients and specialized solutions to a global customer base across industrial and agricultural markets.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from Tata Chemicals Limited dated February 2, 2026, regarding the outcome of a Board Meeting where the unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2025, were approved. It includes a Limited Review Report by auditors B S R & Co. LLP, which reviews the interim financial results for the quarter and nine months ended December 31, 2025. The document contains substantive financial data, including income, expenses, profit/loss, tax expenses, earnings per share, and segment-wise revenue and results. The presence of interim financial statements and the auditor's limited review report indicates this is an Interim / Quarterly Report. The document is not merely an announcement of a report but contains the actual financial results and auditor's review, fulfilling the criteria for classification as an Interim / Quarterly Report (IR). 9M 2026
2026-02-02 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notification about an upcoming Analysts’/Investors Call scheduled for February 2, 2026, to discuss the company's Q3 and 9 months FY26 financial performance. It includes details about the call timing, dial-in numbers, and participants. The document does not contain any financial data or results itself, but rather informs about the event where such information will be discussed. The document length is 2819 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript (CT) announcement or invitation. However, since it is only an intimation of the call and not the transcript itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the call. But given the specific nature of the announcement about the call, the best fit is Call Transcript (CT) category as it relates directly to the earnings call event.
2026-01-21 English
Intimation of Analysts'/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming Analysts’/Investors Call to discuss the company's Q3 & 9M FY26 financial performance. It includes details about the call timing, dial-in numbers, and participants but does not contain any financial data or results itself. The document length is 2819 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement or invitation, but since it does not contain the transcript itself, it is an announcement of the call. According to the filing definitions, announcements about calls fall under Call Transcript (CT) category only if they contain the full transcript. Since this is only an intimation of the call, it is best classified as Regulatory Filings (RNS) as a general regulatory announcement under SEBI Listing Regulations.
2026-01-21 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying about an upcoming Board Meeting scheduled for February 2, 2026. The purpose of the meeting is to consider and approve the unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2025. The letter also mentions the closure of the trading window in compliance with insider trading regulations. The document is short (1583 characters) and serves as an intimation or announcement of a future event (Board Meeting) rather than containing any financial results or detailed report itself. It references regulatory provisions related to disclosures but does not include any financial data or report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit into other specific categories like Interim Report or Earnings Release. It is not a report publication announcement since it does not mention the release or availability of a report, only the scheduling of a meeting to approve results.
2026-01-21 English
Tata Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Unaudited Consolidated and Audited ....
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for February 2, 2026. The purpose of the meeting is to consider and approve the unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2025. The letter also mentions the closure of the trading window in compliance with insider trading regulations. The document is an announcement of a Board Meeting and does not contain any financial data or detailed report content. It is a regulatory announcement related to board activities, specifically the scheduling of a board meeting to approve financial results. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short (1583 characters), and it is not a report or financial statement itself, but an intimation about a board meeting.
2026-01-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.